methylprednisolone and Kahler Disease

methylprednisolone has been researched along with Kahler Disease in 82 studies

Research

Studies (82)

Timeframe	Studies, this research(%)	All Research%
pre-1990	19 (23.17)	18.7374
1990's	18 (21.95)	18.2507
2000's	31 (37.80)	29.6817
2010's	9 (10.98)	24.3611
2020's	5 (6.10)	2.80

Authors

Authors	Studies
Berenson, JR; Bujarski, S; Eades, BR; Emamy-Sadr, M; Green, T; Souther, E; Spektor, TM; Sutanto, C; Swift, RA; To, J	1
Berenson, JR; Boccia, R; Bujarski, S; Eades, BM; Eshaghian, S; Kim, C; Kim, S; Lim, S; Martinez, D; Moezi, M; Regidor, B; Safaie, T; Schwartz, G; Swift, R; Vescio, R; Yang, H	1
Berenson, JR; Ghermezi, M; Spektor, TM	1
Couto, SCF; Culler, HF; Lage, LAPC; Martinez, GA; Mendes, FR; Pereira, J; Rocha, V; Sobral, KM	1
Ainley, L; Chavda, SJ; Cheesman, S; Counsell, N; Horder, J; Kyriakou, C; Lee, L; Mehta, A; Newrick, F; Papanikolaou, X; Popat, R; Rabin, N; Sive, J; Wechalekar, A; Yong, K	1
Arnulf, B; Claudel, A; Harel, S; Lemaire, P; Madelaine, I; Naelle, L; Royer, B; Talbot, A; Zagdanski, AM	1
Engelhardt, M; Munder, M; Salwender, H; Scheid, C	1
Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K	1
Alkemper, B; Gaede, B; Knauf, W; Reschke, D; Schlag, R; Schmits, R; Schütz, S; Schwarzer, A; Tapprich, C	1
Antonicelli, F; Bernard, P; Hentati-Kallel, M; Le Jan, S; Trussardi-Régnier, A	1
Ed AlTayeb Mussa, M; Eh Samir Ansara, S; El Gamal, TA; El-Bakoury, A; Er Ahmed Sweed, T; Hawkins, A	1
Chen, SL; Hu, Y; Li, X; Zhang, JJ; Zhong, YP	1
Chiba, T; Ito, M; Nakase, H; Yamamoto, S; Yamashita, K	1
Adkins, D; Ratanatharathorn, V; White, B; Yang, H	1
Baker, M	1
An, N; Chen, SL; Hu, Y; Li, X; Zhang, JJ; Zhong, YP	1
Suzuki, K	1
Cheng, LL; Jon, HC; Kwok, AK; Lam, DS; Neoh, EL; Wat, NM	1
Goyal, S; Horton, C; Kulkarni, S; Mehta, J; Millar, B; Powles, R; Rudin, C; Sankpal, S; Saso, R; Singhal, S; Sirohi, B; Treleaven, J	1
Ashcroft, AJ; Child, JA; DasGupta, R; Davies, FE; Drayson, MT; Jack, AS; Morgan, GJ; Owen, RG; Patmore, R; Rawstron, AC	1
Mehta, AB; Shaw, B	1
Hanna, M; Mackinnon, S; Ward, KN; White, RP	1
Brito-Babapulle, F; Fielden, J; Rechner, I	1
Bader, P; Bamberg, M; Einsele, H; Faul, C; Hebart, H; Kanz, L; Liebisch, P; Meisner, C; Plasswilm, L; Schäfer, HJ	1
Dine, G; Dufer, J; Genty, V	1
Ardeshna, KM; Bhattacharya, S; D'Sa, S; Foulkes, B; Goldstone, AH; Ings, SJ; Kyriakou, C; Peggs, KS; Watts, MJ; Williams, CD; Yong, K	1
Ausch, C; Buxhofer-Ausch, V; Habertheuer, KH; Hinterberger, W; Hinterberger-Fischer, M; Hruby, W; Kier, P; Ogris, E; Reiner-Concin, A; Ruckser, R; Schmid, I; Sebesta, C; Tatzreiter, G; Zelenka, P	1
Ferrant, A; Jacquemain, A; Knoops, L; Tennstedt, D; Theate, I; Van den Neste, E	1
Horton, C; Kulkarni, S; Mehta, J; Powles, R; Rudin, C; Saso, R; Singhal, S; Sirohi, B; Treleaven, J	1
Dine, G; Dufer, J; El-Khoury, V; Genty, V; Liautaud-Roger, F	1
Agarwal, PK; Gogia, A; Jain, KP; Jain, S	1
Chim, CS; Ooi, GC	1
De Raeve, H; Lambert, J; Rombouts, S; Schroyens, W; Van de Velde, A; Van de Voorde, K; Van Regenmortel, N	1
Jagannath, S	1
Abonour, R; Juliar, BE; Smith, GG; Suvannasankha, A	1
Alvares, CL; Davies, FE; Dines, S; Ethell, ME; Horton, C; Jenner, MW; Krishnan, B; McCormack, R; Morgan, GJ; Potter, MN; Saso, R; Treleaven, JG; Wu, P	1
Casper, J; Freund, M; Hilgendorf, I; Junghanss, C; Prall, F; Sviland, L; Wolff, D	1
Cavanagh, J; Dyer, P; Horton, C; Kulkarni, S; Morgan, G; Oakervee, H; Powles, R; Rintala, T; Rudin, C; Sirohi, B; Treleaven, J	1
Astori, C; Castagnola, C; Corso, A; Dore, R; Lazzarino, M; Mangiacavalli, S; Varettoni, M; Zappasodi, P	1
Halie, MR; Marrink, J; Nieweg, HO; Ockhuizen, T; Piersma, H; van Dobbenburgh, OA	1
Costanzo, R; Di Filippo, S; Locatelli, F; Marai, P; Pedrini, L; Ponti, R; Pozzi, C	1
Chen, MG; Garton, JP; Gertz, MA; Greipp, PR; Inwards, DJ; Letendre, L; Litzow, MR; Pineda, AA; Solberg, LA; Witzig, TE	1
Bozek, T; Corringham, R; Corringham, S; Germond, C; Goss, G; Helie, G; Koski, T; Sinoff, C; Vincent, M	1
Holománová, D; Lipsic, T; Mikulecký, M; Mistrík, M; Sakalová, A; Steruská, M	1
Ala-Harja, K; Almqvist, A; Elonen, E; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Palva, IP	1
Garton, JP; Gertz, MA; Greipp, PR; Kyle, RA; Witzig, TE	1
Addessi, MA; Afeltra, A; Amoroso, A; Bonomo, L; Garzia, P; Pulsoni, A	1
Lyn, BE; Mahendra, P; McMillan, AM; Shaw, B; Somers, LJ	1
Usnarska-Zubkiewicz, L	1
Bhagwati, N; Horton, C; Kulkarni, S; Mehta, J; Powles, R; Raje, N; Ramiah, V; Saso, R; Singhal, S; Sirohi, B; Treleaven, J	1
Kulkarni, S; Mainwaring, PN; Powles, RL; Raje, N; Ramiah, V; Sumpter, K; Treleaven, J	1
Bhagwati, N; Horton, C; Kulkarni, S; Mainwaring, P; Mehta, J; Pandha, H; Powles, R; Singhal, S; Sirohi, B; Treleaven, J	1
Child, JA; Davies, FE; Drayson, M; Evans, PA; Forsyth, PD; Morgan, GJ; Owen, RG; Pratt, G; Rawstron, AC; Richards, SJ; Selby, PJ; Smith, GM	1
Imai, K; Kawamura, T; Kondo, K; Sakurai, H; Sato, T; Takemori, N	1
Bock, PR; Chabronová, I; Dedík, L; Gazová, S; Hanisch, J; Holomanova, D; Hrubisko, M; Mistrík, M; Sakalová, A; Schiess, W	1
Bhagwati, N; Horton, C; Kulkarni, S; Mehta, J; Parikh, R; Powles, R; Raje, N; Rudin, C; Saso, R; Singhal, S; Sirohi, B; Treleaven, J	1
Lambert, J; Meuleman, L; Nijsten, T; Schroyens, W	1
Diem, E; Konrad, K; Pehamberger, H	1
Azzoni, P; Dal Negro, R; Turco, P	1
Dell'Oro, C; Locatelli, F; Pozzi, C	1
Fritsch, H; Höltermann, F; Klug, S	1
Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC	1
Akimoto, Y; Hino, K; Iguchi, K; Ishiyama, T; Kawakami, K; Nakamaki, T; Sato, S; Suzuki, K; Tomoyasu, S; Ueno, H	1
Gore, ME; Malpas, JS; McElwain, TJ; Meldrum, M; Millar, BC	1
Bell, JB; Gore, ME; Maitland, JA; McElwain, TJ; Millar, BC; Montes, A; Treleaven, J	1
Aitchison, RG; Morgan, AG; Reilly, IA; Russell, NH	1
Bell, J; Clark, PI; Gore, ME; Judson, IR; Maitland, JA; Meldrum, M; Milan, S; Millar, B; Selby, PJ; Viner, C	1
Ahrenberg, P; Ala-Harja, K; Almqvist, A; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Kilpi, H; Palva, IP	1
Gore, ME; Judson, IR; Malpas, JS; McElwain, TJ; Meldrum, M; Viner, C	1
Gore, ME; Malpas, JS; McElwain, TJ; Meldrum, M; Millar, BC; Selby, PJ; Viner, C	1
Fukuzawa, Y; Kawamura, T; Ohno, R	1
Bell, JB; Gore, M; Maitland, JA; McElwain, TJ; Millar, BC; Nandi, A	1
Bell, JB; Gore, ME; Maitland, JA; McElwain, TJ; Millar, BC; Selby, PJ; Zuiable, A	1
Cagnoli, L; Ferrari, G; Pasquali, S; Zucchelli, P	1
Forgeson, GV; Lakhani, S; Maitland, J; McElwain, TJ; Selby, P; Viner, C; Zulian, G	1
Bury, J; Fillet, G; Salmon, J	1
Ahrenberg, P; Ala-Harja, K; Almqvist, A; Apajalahti, J; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Palva, IP	1
Latos, DL; Valentine, AM	1
Abramson, N; Ginsburg, AD; von Kapff, C	1

Reviews

5 review(s) available for methylprednisolone and Kahler Disease

Article	Year
The role of JAK inhibitors in multiple myeloma. Clinical advances in hematology & oncology : H&O, 2019, Volume: 17, Issue:9 Topics: Dexamethasone; Humans; Janus Kinase 1; Janus Kinase 2; Lenalidomide; Methylprednisolone; Multiple Myeloma; Neoplasm Proteins; Nitriles; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines	2019
Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review. Medicine, 2020, Sep-25, Volume: 99, Issue:39 Topics: Anemia; Antineoplastic Agents, Alkylating; Bone Marrow; Brazil; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Fatal Outcome; Fever; Glucocorticoids; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Multiple Organ Failure; Paraproteinemias; Plasma Cells; Splenomegaly; Thrombocytopenia; Weight Loss	2020
Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion. Clinical and experimental nephrology, 2012, Volume: 16, Issue:5 Topics: Aged; Amyloidosis; Bence Jones Protein; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulin Light-chain Amyloidosis; Kidney; Lenalidomide; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Pyrazines; Renal Insufficiency; Thalidomide	2012
Systemic lupus erythematosus and multiple myeloma: a rare association. Seminars in arthritis and rheumatism, 1997, Volume: 26, Issue:6 Topics: Antineoplastic Agents; Cyclophosphamide; Female; Humans; Interferon alpha-2; Interferon-alpha; Lupus Erythematosus, Systemic; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Recombinant Proteins; Recurrence	1997
High-dose chemotherapy and autologous bone marrow transplantation for myeloma. European journal of haematology. Supplementum, 1989, Volume: 51 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Doxorubicin; Evaluation Studies as Topic; Humans; Melphalan; Methylprednisolone; Multiple Myeloma; Remission Induction; Transplantation, Autologous; Vincristine	1989

Trials

17 trial(s) available for methylprednisolone and Kahler Disease

Article	Year
Use of serum B-cell maturation antigen levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone. Hematological oncology, 2022, Volume: 40, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; B-Cell Maturation Antigen; Dexamethasone; Humans; Lenalidomide; Methylprednisolone; Multiple Myeloma; Nitriles; Prospective Studies; Pyrazoles; Pyrimidines	2022
Bortezomib-containing regimens are effective in multiple myeloma--results of a non-interventional phase IV study. Oncology research and treatment, 2015, Volume: 38, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prospective Studies	2015
[Bortezomib combined with other drugs for treating 60 cases of multiple myeloma]. Zhongguo shi yan xue ye xue za zhi, 2009, Volume: 17, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Pyrazines; Thalidomide; Treatment Outcome	2009
Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease. Transplantation, 2009, Jul-27, Volume: 88, Issue:2 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methylprednisolone; Multiple Myeloma; Safety; Treatment Outcome	2009
Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'? Bone marrow transplantation, 2002, Volume: 30, Issue:8 Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine	2002
Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma. Clinical lymphoma & myeloma, 2006, Volume: 7, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Pyrazines; Recurrence; Stem Cell Transplantation; Survival Rate	2006
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1993, Volume: 51, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Leukemia, Myeloid, Acute; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Vincristine	1993
A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma. Leukemia, 1995, Volume: 9, Issue:12 Topics: Adult; Aged; Connectin; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Muscle Proteins; Myeloma Proteins; Recurrence; Survival Analysis	1995
[Level of interleukin-6 (IL-6), soluble interleukin-6 receptors (sIL-6R) and tumor necrosis factor alpha (TNF-alpha) in untreated and progressing multiple myeloma]. Polskie Archiwum Medycyny Wewnetrznej, 1998, Volume: 99, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease Progression; Female; Humans; Interleukin-6; Kidney Failure, Chronic; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisone; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Survival Rate; Tumor Necrosis Factor-alpha; Vincristine	1998
Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma. Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Humans; Idarubicin; Methylprednisolone; Middle Aged; Multiple Myeloma; Remission Induction; Salvage Therapy; Thrombocytopenia; Treatment Failure; Vincristine	1999
The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone marrow transplantation, 2000, Volume: 25, Issue:5 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Graft Survival; Heart Diseases; Hematopoietic Stem Cell Mobilization; Hospitalization; Humans; Interferons; Kidney Diseases; Male; Matched-Pair Analysis; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neutropenia; Neutrophils; Platelet Count; Recurrence; Sepsis; Survival Rate; Thrombocytopenia; Transplantation, Autologous; Vincristine	2000
Combination chemotherapy MOCCA in resistant and relapsing multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1992, Volume: 48, Issue:1 Topics: Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Light Chains; Lomustine; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasm Staging; Recurrence; Treatment Outcome; Vincristine	1992
Treatment of multiple myeloma in old patients. Finnish Leukaemia Group. European journal of haematology, 1989, Volume: 43, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lomustine; Melphalan; Methylprednisolone; Multiple Myeloma; Vincristine	1989
VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma. Bone marrow transplantation, 1989, Volume: 4 Suppl 4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Transplantation, Autologous; Vincristine	1989
Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney international, 1988, Volume: 33, Issue:6 Topics: Acute Kidney Injury; Aged; Bence Jones Protein; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Peritoneal Dialysis; Plasma Exchange; Prednisolone; Random Allocation; Renal Dialysis	1988
Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia Group. European journal of haematology, 1987, Volume: 38, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Immunoglobulins; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisone; Vincristine	1987
Aggressive combination chemotherapy in multiple myeloma. A multicentre trial. Finnish Leukaemia Group. Scandinavian journal of haematology, 1985, Volume: 35, Issue:2 Topics: Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prognosis; Vincristine	1985

Other Studies

60 other study(ies) available for methylprednisolone and Kahler Disease

Article	Year
Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma. British journal of haematology, 2023, Volume: 200, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; In Situ Hybridization, Fluorescence; Methylprednisolone; Multiple Myeloma; Pyrimidines	2023
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation. British journal of haematology, 2021, Volume: 192, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Progression-Free Survival; Salvage Therapy; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Young Adult	2021
Thiotepa intrathecal injections for myelomatous central nervous system involvement. British journal of haematology, 2021, Volume: 193, Issue:2 Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Female; Humans; Incidence; Injections, Spinal; Male; Meningeal Neoplasms; Methylprednisolone; Middle Aged; Multiple Myeloma; Neuroprotective Agents; Plasmacytoma; Safety; Thiotepa; Treatment Outcome	2021
[Infusion of Daratumumab in Combination Therapies - Practical Information for The Outpatient Area]. Deutsche medizinische Wochenschrift (1946), 2018, Volume: 143, Issue:16 Topics: Acetates; Ambulatory Care; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclopropanes; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Methylprednisolone; Multiple Myeloma; Premedication; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Time Factors	2018
Myeloma presenting during pregnancy. Hematological oncology, 2014, Volume: 32, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous	2014
Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines. International journal of oncology, 2017, Volume: 50, Issue:2 Topics: Benzamides; Cell Line; Dexamethasone; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glucocorticoids; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Matrix Metalloproteinase 9; Methylprednisolone; MicroRNAs; Multiple Myeloma; Pyridines	2017
Bilateral Osteonecrosis of the Femoral and Humeral Heads after Short Term Corticosteroid Therapy. A Case Study. Ortopedia, traumatologia, rehabilitacja, 2016, Mar-23, Volume: 18, Issue:2 Topics: Femur Head Necrosis; Humans; Humerus; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Osteonecrosis; Prednisone	2016
Clinical challenges and images in GI. Image 4. Transplant-associated thrombotic microangiopathy of the colon accompanied by graft-versus-host disease. Gastroenterology, 2009, Volume: 136, Issue:7 Topics: Adult; Biopsy, Needle; Colonoscopy; Diarrhea; Disease Progression; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunohistochemistry; Male; Methylprednisolone; Multiple Myeloma; Purpura, Thrombotic Thrombocytopenic; Risk Factors; Severity of Illness Index	2009
Graft-versus-host disease following autologous transplantation. Oncology nursing forum, 2010, Volume: 37, Issue:3 Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methylprednisolone; Multiple Myeloma; Nurse's Role; Nursing Assessment; Oncology Nursing; Transplantation, Autologous	2010
[Effects of bortezomib combined with methylprednisolone in treatment of 33 cases of relapsed or refractory multiple myeloma]. Zhongguo shi yan xue ye xue za zhi, 2011, Volume: 19, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Pyrazines; Retrospective Studies; Treatment Outcome	2011
Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant. American journal of ophthalmology, 2002, Volume: 134, Issue:2 Topics: Antilymphocyte Serum; Bone Marrow Transplantation; Choroid Diseases; Conjunctival Diseases; Cyclosporine; Female; Fluorescein Angiography; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Multiple Myeloma; Retinal Diseases; Vision Disorders; Visual Acuity	2002
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood, 2002, Nov-01, Volume: 100, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Count; Combined Modality Therapy; Consensus Sequence; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Flow Cytometry; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin Heavy Chains; Life Tables; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Multivariate Analysis; Myeloma Proteins; Neoplasm, Residual; Neoplastic Stem Cells; Plasma Cells; Polymerase Chain Reaction; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine	2002
Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. Clinical and laboratory haematology, 2002, Volume: 24, Issue:6 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Carbimazole; Cyclophosphamide; Doxorubicin; Graves Disease; Gynecomastia; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Ribs; Spinal Neoplasms; Thoracic Vertebrae; Transplantation Conditioning; Transplantation, Autologous; Vincristine	2002
Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. Bone marrow transplantation, 2002, Volume: 30, Issue:12 Topics: Anti-Inflammatory Agents; Bone Marrow Transplantation; Cerebrospinal Fluid; Graft vs Host Disease; Herpesvirus 7, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Myelitis; Paraparesis, Spastic; Roseolovirus Infections; Transplantation, Homologous; Urinary Bladder, Neurogenic; Virus Activation	2002
Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF). The hematology journal : the official journal of the European Haematology Association, 2003, Volume: 4, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capillary Leak Syndrome; Combined Modality Therapy; Critical Care; Cyclophosphamide; Dexamethasone; Doxorubicin; Dyspnea; Edema; Fasciitis, Necrotizing; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Models, Biological; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Thalidomide; Vasculitis, Leukocytoclastic, Cutaneous; Vincristine	2003
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning. British journal of haematology, 2003, Volume: 121, Issue:3 Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Chronic Disease; Cyclosporine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous	2003
Phenotypical alterations induced by glucocorticoids resistance in RPMI 8226 human myeloma cells. Leukemia research, 2004, Volume: 28, Issue:3 Topics: Antigens, CD; Cell Line, Tumor; Dexamethasone; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Methylprednisolone; Multiple Myeloma; Phenotype; Prednisolone; Prednisone	2004
Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. British journal of haematology, 2004, Volume: 125, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Plasma Cells	2004
A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma. European journal of haematology, 2004, Volume: 73, Issue:2 Topics: Anthracyclines; Female; Heart Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Interstitial; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2004
Bortezomib-induced Sweet syndrome. British journal of haematology, 2005, Volume: 131, Issue:2 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Pyrazines; Sweet Syndrome	2005
Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft. Hematology (Amsterdam, Netherlands), 2005, Volume: 10, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Recurrence; Retrospective Studies; Salvage Therapy; Transplantation, Autologous; Vincristine	2005
Nuclear chromatin patterns in 3 glucocorticoid-resistant RPMI 8226 human myeloma cell sub-lines: correlations with cell growth and immunological phenotype. Cancer biology & therapy, 2005, Volume: 4, Issue:8 Topics: ADP-ribosyl Cyclase 1; Antineoplastic Agents, Hormonal; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Chromatin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Glucocorticoids; Humans; Hyaluronan Receptors; Methylprednisolone; Multiple Myeloma; Phenotype; Prednisone	2005
Myelomatous pleural effusion. The Journal of the Association of Physicians of India, 2005, Volume: 53 Topics: Aged; Cyclophosphamide; Humans; Male; Methylprednisolone; Multiple Myeloma; Pleural Effusion	2005
Bulbar palsy in multiple myeloma. Haematologica, 2005, Volume: 90, Issue:12 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Bulbar Palsy, Progressive; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Nerve Diseases; Cyclosporine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin Light Chains; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pneumonia, Aspiration; Pyrazines; Reflex, Abnormal; Transplantation, Homologous; Vincristine	2005
Bortezomib-induced Sweet's syndrome. Haematologica, 2005, Volume: 90, Issue:12 Suppl Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Drug Administration Schedule; Erectile Dysfunction; Humans; Immunosuppressive Agents; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Pain; Peripheral Nervous System Diseases; Prednisolone; Protease Inhibitors; Pyrazines; Recurrence; Sleep Initiation and Maintenance Disorders; Sweet Syndrome; Testicular Diseases	2005
Bortezomib dosing in relapsed multiple myeloma. Clinical lymphoma & myeloma, 2006, Volume: 7, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Pyrazines; Recurrence; Stem Cell Transplantation; Survival Rate	2006
The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide - vincristine - doxorubicin - methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case- Leukemia & lymphoma, 2006, Volume: 47, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Case-Control Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Vincristine	2006
Toxic epidermal necrolysis after allogeneic haematopoietic stem cell transplantation. Bone marrow transplantation, 2007, Volume: 39, Issue:4 Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Female; Hematopoietic Stem Cell Transplantation; Histocytochemistry; Humans; Methylprednisolone; Multiple Myeloma; Stevens-Johnson Syndrome; Transplantation, Homologous	2007
Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy. Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lenograstim; Leukapheresis; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Remission Induction; Time Factors; Vincristine	2007
Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-01, Volume: 25, Issue:22 Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Cryptogenic Organizing Pneumonia; Glucocorticoids; Humans; Male; Methylprednisolone; Multiple Myeloma; Pyrazines; Tomography, X-Ray Computed	2007
Multiple myeloma with high tumour mass. Treatment with high-dose methylprednisolone, cyclophosphamide and vindesine. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Cyclophosphamide; Female; Humans; Immunoglobulins; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Vinblastine; Vindesine	1984
Steroid pulses and plasmapheresis in the treatment of acute renal failure in multiple myeloma. Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association, 1980, Volume: 17 Topics: Acute Kidney Injury; Creatinine; Humans; Immunoglobulin G; Methylprednisolone; Multiple Myeloma; Plasmapheresis; Proteinuria	1980
Refractory and relapsing multiple myeloma treated by blood stem cell transplantation. The American journal of the medical sciences, 1995, Volume: 309, Issue:3 Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Male; Melphalan; Methylprednisolone; Middle Aged; Mucous Membrane; Multiple Myeloma; Pharyngitis; Recurrence; Whole-Body Irradiation	1995
Bi-weekly vincristine, epirubicin and methylprednisolone in alkylator-refractory multiple myeloma. Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:4 Topics: Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Epirubicin; Feasibility Studies; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Vincristine	1994
Prognostic value of plasma-cell immunophenotype in patients with multiple myeloma. Neoplasma, 1993, Volume: 40, Issue:6 Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; HLA-DR Antigens; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Isotypes; Immunophenotyping; Lomustine; Longitudinal Studies; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Plasma Cells; Prednisone; Prognosis; Regression Analysis; Survival Analysis; Vincristine	1993
Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression. Clinical and laboratory haematology, 1998, Volume: 20, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Doxorubicin; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunoglobulin lambda-Chains; Injections, Spinal; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Staging; Ribs; Vincristine	1998
Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system. British journal of haematology, 1999, Volume: 107, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Immunoglobulin A; Immunoglobulin G; Interferons; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Prognosis; Recurrence; Vincristine	1999
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma. British journal of haematology, 2001, Volume: 112, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bence Jones Protein; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Electrophoresis; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Multivariate Analysis; Neoplasm, Residual; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Vincristine	2001
Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment. American journal of hematology, 2001, Volume: 66, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Glucocorticoids; Humans; Immunoglobulin D; Immunoglobulin lambda-Chains; Interferons; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Nitrosourea Compounds; Prednisolone; Remission Induction; Vincristine	2001
Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer chemotherapy and pharmacology, 2001, Volume: 47 Suppl Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chymotrypsin; Cohort Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Combinations; Endopeptidases; Female; Humans; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Papain; Prednisone; Proportional Hazards Models; Retrospective Studies; Survival Rate; Trypsin; Vincristine	2001
The implication of compromised renal function at presentation in myeloma: similar outcome in patients who receive high-dose therapy: a single-center study of 251 previously untreated patients. Medical oncology (Northwood, London, England), 2001, Volume: 18, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Creatinine; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Interferons; Kidney Diseases; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Retrospective Studies; Survival Analysis; Vincristine	2001
Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisolone. Dermatology (Basel, Switzerland), 2002, Volume: 204, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Drug Eruptions; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Myeloma; Thalidomide	2002
Systemic lupus erythematosus with multiple myeloma. Acta dermato-venereologica, 1978, Volume: 58, Issue:6 Topics: Adult; Cyclophosphamide; Fluorescent Antibody Technique; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Multiple Myeloma; Skin	1978
[6-methylprednisolone acetate (6-MPA): an alternative treatment in oncology]. Minerva medica, 1978, Sep-15, Volume: 69, Issue:42 Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Lung Neoplasms; Lymphoma; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasms; Sigmoid Neoplasms; Uterine Cervical Neoplasms	1978
Adverse reaction during methylprednisolone pulse. Nephron, 1992, Volume: 60, Issue:2 Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Kidney Diseases; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisolone; Vincristine	1992
[IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia]. Deutsche medizinische Wochenschrift (1946), 1992, Jun-05, Volume: 117, Issue:23 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aortic Valve Insufficiency; Drug Therapy, Combination; Female; Humans; Immunoglobulin lambda-Chains; Leukemia, Plasma Cell; Melphalan; Methylprednisolone; Mitral Valve Stenosis; Multiple Myeloma; Pericardial Effusion; Plasma Cells	1992
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone. American journal of hematology, 1991, Volume: 38, Issue:4 Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes	1991
[Clinical investigation on acute respiratory failure in patients with severe hematologic malignancy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1991, Volume: 32, Issue:8 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Humans; Leukemia; Lymphoma; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Respiratory Insufficiency	1991
Intensive therapy for myeloma. Pathologie-biologie, 1990, Volume: 38, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Bone Marrow Transplantation; Humans; Melphalan; Methotrexate; Methylprednisolone; Multiple Myeloma; Prednisolone; Vincristine	1990
Evidence that multiple myeloma may be regulated by homeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical response. British journal of cancer, 1990, Volume: 61, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin; Homeostasis; Humans; Melphalan; Methylprednisolone; Multiple Myeloma; Tumor Stem Cell Assay; Vincristine	1990
Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure. British journal of cancer, 1990, Volume: 61, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Doxorubicin; Humans; Kidney Diseases; Methylprednisolone; Middle Aged; Multiple Myeloma; Vincristine	1990
Intensive treatment of multiple myeloma and criteria for complete remission. Lancet (London, England), 1989, Oct-14, Volume: 2, Issue:8668 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Bone Marrow Transplantation; Doxorubicin; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Immunoglobulins; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Remission Induction; Time Factors; Vincristine	1989
Improved long-term survival in multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1989, Volume: 43, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Finland; Humans; Lomustine; Melphalan; Methylprednisolone; Multiple Myeloma; Prognosis; Remission Induction; Survival Analysis; Time Factors; Vincristine	1989
[Clinical trial of a combination of human lymphoblastoid interferon (HLBI) and methyl-prednisolone (HLBI-mP) in multiple myeloma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11 Topics: Aged; Combined Modality Therapy; Drug Evaluation; Female; Humans; Interferon Type I; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Remission Induction	1989
Increase in clonogenic tumour cells in bone marrow of patients with multiple myeloma treated with vincristine, doxorubicin, and methylprednisolone. Lancet (London, England), 1988, Oct-22, Volume: 2, Issue:8617 Topics: Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; Doxorubicin; Humans; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Tumor Stem Cell Assay; Vincristine	1988
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myeloma. British journal of haematology, 1989, Volume: 71, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Survival; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Melphalan; Methylprednisolone; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay; Verapamil; Vincristine	1989
Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients. British journal of cancer, 1988, Volume: 58, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Cyclophosphamide; Doxorubicin; Female; Humans; Infections; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Vincristine	1988
[Monoclonal gammapathy of indeterminate origin and myeloma]. Revue medicale de Liege, 1988, Apr-15, Volume: 43, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Drug Therapy, Combination; Humans; Hypergammaglobulinemia; Interferon Type I; Melphalan; Methylprednisolone; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Prednisone; Vincristine	1988
Treatment of hypercalcemia with furosemide and corticosteroids. The West Virginia medical journal, 1973, Volume: 69, Issue:3 Topics: Female; Furosemide; Humans; Hypercalcemia; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisone	1973
The phagocytic plasma cells. The New England journal of medicine, 1970, Jul-30, Volume: 283, Issue:5 Topics: Aged; Bone Marrow; Bone Marrow Cells; Female; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Phagocytosis; Plasma Cells	1970